AZRX AzurRx BioPharma SEC filings

DEFA14A

AZRX AzurRx BioPharma Inc

20 Jan 21

Additional proxy soliciting materials

DEF 14A

AZRX AzurRx BioPharma Inc

19 Jan 21

Definitive proxy

S-1

AZRX AzurRx BioPharma Inc

13 Jan 21

IPO registration

8-K/A

AZRX AzurRx BioPharma Inc

13 Jan 21

Financial Statements and Exhibits

PRE 14A

AZRX AzurRx BioPharma Inc

8 Jan 21

Preliminary proxy

8-K

AZRX AzurRx BioPharma Inc

8 Jan 21

Entry into a Material Definitive Agreement

4

Gregory Oakes

7 Jan 21

AzurRx BioPharma / Gregory Oakes ownership change

4

Schramm Vern Lee

7 Jan 21

AzurRx BioPharma / Vern Lee Schramm ownership change

4

Riddell Alastair

7 Jan 21

AzurRx BioPharma / Alastair Riddell ownership change

4

Casamento Charles J

7 Jan 21

AzurRx BioPharma / CHARLES J CASAMENTO ownership change

4

AZRX AzurRx BioPharma Inc

7 Jan 21

AzurRx BioPharma / EDWARD BORKOWSKI ownership change

8-K

AZRX AzurRx BioPharma Inc

5 Jan 21

Other Events

424B5

AZRX AzurRx BioPharma Inc

5 Jan 21

Prospectus supplement for primary offering

8-K

AZRX AzurRx BioPharma Inc

4 Jan 21

Agreement expands AzurRx’s pipeline of targeted, non-systemic GI therapies

8-K

AZRX AzurRx BioPharma Inc

7 Dec 20

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

8-K

AZRX AzurRx BioPharma Inc

17 Nov 20

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

10-Q

2020 Q3

AZRX AzurRx BioPharma Inc

16 Nov 20

Quarterly report

EFFECT

AZRX AzurRx BioPharma Inc

22 Sep 20

Notice of effectiveness

424B3

AZRX AzurRx BioPharma Inc

21 Sep 20

Prospectus supplement

S-3/A

AZRX AzurRx BioPharma Inc

17 Sep 20

Shelf registration (amended)